When a hospice patient is actively dying at home, the family — not a hospital — manages the crisis, guided by a pre-placed kit of medications. Here is the pharmacology behind that kit, and why the drug log keeps it DEA-compliant.
When the Living Room Is the Unit
In home hospice, the crisis does not arrive at a resuscitation bay. It arrives in a bedroom, at 0300, with a frightened family member and a small box of pre-placed medications — the comfort kit (sometimes an e-kit) the agency positioned in the home for exactly this moment. Knowing what is in that kit and why is part of supporting these patients and the nurses who manage them.
Terminal Dyspnea: Opioids, Not Oxygen
Air hunger near the end of life is one of the most distressing symptoms a family will witness. The counterintuitive, evidence-based answer is the opioid, not the oxygen tank.
- Low-dose opioids (morphine) are first-line. They blunt the ventilatory drive's response to hypercapnia and hypoxia and directly reduce the *sensation* of breathlessness. Dosing is low and titrated to comfort, not to a respiratory number.
- Oxygen is frequently not beneficial in a patient who is not hypoxemic; air hunger and low oxygen saturation are not the same problem. A fan moving air across the face often helps more than a cannula.
The goal here is comfort. We are treating the symptom of suffocation, not chasing a SpO2 target.
The Death Rattle: Reposition First, Then Dry the Secretions
The "death rattle" is the noisy breathing caused by pooled oropharyngeal secretions in a patient who has lost the ability to swallow or cough. It distresses families more than it distresses the (usually unconscious) patient.
- Reposition first — lateral or semi-prone positioning lets secretions drain and is often enough.
- Antimuscarinics dry secretions when needed: glycopyrrolate, atropine ophthalmic drops given sublingually, and scopolamine (hyoscine). They reduce new secretion production — they do not clear what has already pooled, which is why early use and repositioning matter.
Terminal Agitation and Restlessness
Restlessness at the end of life can be delirium, pain, a full bladder, or fear — assess before you sedate.
- Lorazepam for agitation and anxiety.
- Haloperidol for terminal delirium.
- Distinguish agitation from uncontrolled pain; the answer is different for each.
| Symptom | Drug | Route | Mechanism |
|---|---|---|---|
| Dyspnea / air hunger | Morphine (low dose) | PO / SL / SC | Reduces ventilatory drive + sensation of breathlessness |
| Terminal secretions | Glycopyrrolate, atropine drops, scopolamine | SL / SC / transdermal | Antimuscarinic — reduces secretion production |
| Agitation / anxiety | Lorazepam | SL / PO | Anxiolysis, sedation |
| Terminal delirium | Haloperidol | PO / SC | Antipsychotic |
The Compliance Layer Nobody Sees
Every controlled medication in that kit lives under the same DEA obligations I have written about before: accurate recordkeeping under 21 CFR Part 1304, witnessed wasting of unused narcotics, and a defensible chain of custody from pharmacy to bedside to disposal. In a home, securing a second signature and documenting a waste is logistically hard — which is exactly why mobile drug-log tooling exists. The clinical job is comfort; the regulatory job is proving, after the fact, that every milligram is accounted for.
Curated by Jonathan B
Tracking the tools of tomorrow